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Importance 
Equine viral arteritis (EVA) is an economically important viral disease of equids. 
Stallions can become long term carriers of the virus, and transmit it during breeding. 
Although carrier stallions can be bred if precautions are taken, the need to mate them 
with seropositive or vaccinated mares decreases their desirability as breeders. Acute 
illness also occurs in some horses. Although deaths are very rare in healthy adults, 
pregnant mares that become infected may abort, and very young foals may die of 
fulminating pneumonia and enteritis. Equine viral arteritis has recently increased in 
prevalence, possibly due to increased transportation of horses and semen. 
Etiology 
Equine viral arteritis is caused by equine arteritis virus (EAV), an RNA virus in 
the genus Arterivirus, family Arteriviridae and order Nidovirales. Isolates vary in 
their virulence and potential to induce abortions. Only one serotype has been 
recognized. Limited genetic analysis suggests that EAV strains found among donkeys 
in South Africa may differ significantly from isolates in North America and Europe. 
Species Affected 
Equine arteritis virus is found in the Equidae. Antibodies to this virus have been 
reported in horses, ponies, donkeys and zebras. Illness occurs mainly among horses 
and ponies, but clinical signs have also been reported in experimentally infected 
donkeys. EAV might also be able to cause disease in South American camelids: 
polymerase chain reaction assay (PCR) detected viral nucleic acids in an alpaca that 
had aborted. 
Geographic Distribution 
Antibodies to EAV have been found in most countries where testing has been 
done. Seropositive horses have been reported in North and South America, Europe, 
Asia, Africa and Australia. Infections are common among horses in continental 
Europe, but rare in the United Kingdom. This virus appears to be absent from Iceland 
and Japan.  
Transmission 
Equine arteritis virus can be transmitted by the respiratory and the venereal 
routes. Acutely affected horses excrete the virus in respiratory secretions; aerosol 
transmission is common when horses are gathered at racetracks, sales, shows and 
other events. This virus has also been found in urine and feces during the acute stage. 
It occurs in the reproductive tract of acutely infected mares, and both acutely and 
chronically infected stallions. In mares, EAV can be found in vaginal and uterine 
secretions, as well as in the ovary and oviduct, for a short period after infection. 
Mares infected late in pregnancy may give birth to infected foals. Stallions shed EAV 
in semen, and can carry the virus for years. Transmission from stallions can occur by 
natural service or artificial insemination. Some carriers may eventually clear the 
infection. True carrier states have not been reported in mares, geldings or sexually 
immature colts; however, EAV can occasionally be found for up to six months in the 
reproductive tract of older prepubertal colts.  
Equine arteritis virus can be transmitted on fomites including equipment, and 
may be spread mechanically by humans or animals. This virus is inactivated in 20–30 
minutes at 56-58ºC (133-136ºF), but can remain viable for 2 to 3 days at 37-38ºC (99-
100ºF) and for up to 75 days at 4-8ºC (39-46ºF). Semen remains infectious after 
freezing.  
Incubation Period 
The incubation period varies from 2 days to 2 weeks. Infections transmitted 
venereally tend to become apparent in approximately one week. 
Clinical Signs 
Most EAV infections, especially those that occur in mares bred to long-term 
carriers, are asymptomatic. The clinical signs are generally more severe in old or very  
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young animals, and in horses that are immunocompromised 
or in poor condition. Fulminant infections with severe 
interstitial pneumonia and/ or enteritis can be seen in foals 
up to a few months of age. Systemic illness also occurs in 
some adults. In adult horses, the clinical signs may include 
fever, depression, anorexia, limb edema (particularly in the 
hindlimbs), and dependent edema of the prepuce, scrotum, 
mammary gland and/or ventral body wall. Conjunctivitis, 
photophobia, periorbital or supraorbital edema and rhinitis 
can also be seen. Some horses develop urticaria; the hives 
may be localized to the head or neck, but are sometimes 
generalized. Abortions or stillbirths can occur in mares that 
are pregnant when they are exposed. Abortions are not 
necessarily preceded by systemic signs. Temporary 
decreases in fertility, including reduced quality sperm and 
decreased libido, may be seen in stallions during the acute 
stage of the disease. The decrease in sperm quality has been 
attributed to increased scrotal temperature and edema, and 
can persist for up to 4 months. The quality of the semen is 
not decreased in carrier stallions. Except in cases of severe 
disease in foals, deaths are rare. 
Outbreaks have not been reported among donkeys or 
mules, and although antibodies have been found, there is 
little information on the clinical signs in these species. 
Fever, sometimes accompanied by mild depression, mild 
conjunctivitis, a slight oculonasal discharge and/or mild 
dependent edema were reported in donkeys inoculated with 
an EAV strain that is moderately virulent for horses. The 
clinical signs were mild, and could readily have been 
missed if the animals were not closely monitored. Donkeys 
inoculated with a South African donkey strain developed 
mild to more severe clinical signs including fever, 
depression, serous ocular and nasal discharge, and 
conjunctivitis. Pregnant donkey mares did not abort, and 
their foals were clinically normal when born. Horses 
inoculated with this donkey strain had very mild clinical 
signs. 
Post Mortem Lesions 
In acute cases, the lesions are characterized by edema, 
congestion and hemorrhages of the subcutaneous tissues, 
visceral organs and lymph nodes. These changes are often 
found in the subcutaneous tissues of the limbs and 
abdomen, the thoracic and abdominal lymph nodes, and the 
small and large intestines (especially the colon and cecum), 
but may occur throughout the body. Accumulations of 
clear, yellowish fluid may be found in the peritoneal cavity, 
pleura and pericardium. Foals may also have pulmonary 
edema, interstitial pneumonia, emphysema, splenic infarcts 
and enteritis. In mares that abort, the endometrium may be 
swollen and congested, and can contain hemorrhages. 
Aborted fetuses are often partially autolyzed, but may be 
well preserved. In some fetuses, the only gross lesions may 
be excess fluid in the body cavities and signs of interlobular 
interstitial pneumonia. 
Morbidity and Mortality 
The prevalence of equine arteritis virus varies 
significantly among horse breeds. In the U.S., this infection 
is particularly common among Standardbreds. In a survey 
done in 1998, 24% of unvaccinated Standardbreds, 4.5% of 
Thoroughbreds, 0.6% of Quarter horses, and 3.6% of 
Warmblood horses had antibodies to this virus. In Europe, 
the seroprevalence is particularly high among Warmbloods. 
Breed-related differences in seroprevalence might be due to 
genetic differences, but they are more likely to be caused by 
different management practices. In experimentally infected 
horses, the breed has no apparent effect on susceptibility to 
infection or the establishment of carriers. Overall, 
approximately 10-70% of infected stallions become carriers 
of EAV.  
Outbreaks are much less common than infections, and 
tend to occur when horses have been moved or semen 
shipped. The clinical signs are generally more severe in old 
or very young animals, and in horses that are 
immunocompromised or in poor condition. They also vary 
with the route of exposure, and the strain and dose of the 
virus. Asymptomatic infections are common, and deaths are 
very rare in healthy adults; young foals are more likely to 
die. The abortion rate varies from less than 10% to as high 
as 50-60%.  
Diagnosis 
Clinical 
Equine viral arteritis should be considered when the 
clinical signs include fever, depression, edema, 
conjunctivitis, nasal discharges and abortions. This disease 
is difficult to differentiate from other systemic and 
respiratory illnesses of horses. 
Differential diagnosis 
The differential diagnosis includes equine influenza, 
equine infectious anemia and African horse sickness, as 
well as infections with Getah virus, Hendra virus, equine 
rhinitis A and B viruses, equine adenoviruses, and equine 
herpesviruses 1 and 4. Equine viral arteritis also resembles 
purpura hemorrhagica and other streptococcal infections, as 
well as poisoning from the toxic plant Berteroa incana 
(hoary alyssum).  
Laboratory tests 
Equine viral arteritis can be diagnosed by virus 
isolation, the detection of viral antigens or nucleic acids, 
and serology.  
In recently infected animals, equine arteritis virus may 
be recovered from nasal secretions, blood and semen as 
well as from a number of tissues and fluids at necropsy. 
Carrier stallions can be identified by isolating the virus 
from semen; EAV is not found in the respiratory secretions, 
blood or urine of carriers. This virus can be isolated in 
rabbit, equine and monkey kidney cells or cell lines. RK–13 
(rabbit kidney) cells are the system of choice. The identity 
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of the virus can be confirmed using serum neutralization, 
reverse-transcription PCR (RT-PCR) assays, 
immunofluorescence or immuno-histochemistry. 
RT-PCR can also detect viral nucleic acids in clinical 
samples from live horses or tissues taken at necropsy. 
Immunohistochemistry can identify viral antigens in 
necropsy samples, as well as in skin biopsies from acutely 
infected horses; the latter technique is not completely 
reliable. Histopathology is helpful in clinical cases. 
Serological tests include virus neutralization, 
complement fixation, agar gel immunodiffusion, indirect 
fluorescent antibody, fluorescent microsphere immunoassay 
(MIA) and enzyme–linked immunosorbent assays (ELISA). 
A complement-enhanced micro-neutralization test is often 
used to detect antibodies to EAV. In acute cases, a fourfold 
increase in titer should be seen in serological tests. 
Carriers can also be detected by breeding the stallion to 
two seronegative mares, which are checked for 
seroconversion four weeks after breeding. 
Samples to collect 
In live horses with acute infections, EAV can be 
isolated from nasopharyngeal swabs or washings, 
conjunctival swabs and unclotted blood samples. Because 
heparin may inhibit the growth of RK-13 cells, blood 
samples should be anticoagulated with acid citrate dextrose 
or EDTA. Clinical samples can also be tested by RT-PCR. 
Samples should be collected as soon as possible after the 
onset of the clinical signs. Samples for virus isolation 
should be refrigerated and shipped cold. Carriers can be 
identified by detecting EAV in semen using virus isolation 
or RT-PCR. Semen samples should contain the sperm-rich 
fraction of the ejaculate; virus is not found in the pre-sperm 
fraction. 
At necropsy, tissues should be collected for 
histopathology; the cecum, colon, spleen and associated 
lymph nodes, as well as the adrenal cortex, are especially 
helpful. In aborted fetuses or stillborn foals, samples for 
virus isolation should be taken from the placenta, fetal 
fluids and fetal tissues, especially the lymphoid tissues, 
lung and spleen. In young foals with fatal disease, necropsy 
samples should include a variety of organs and lymph 
nodes associated with the respiratory and gastrointestinal 
tracts; they should include the lungs, liver and spleen. 
Tissue samples can also be collected for RT-PCR and 
immunohistochemistry. EAV antigens can be found in 
organs with or without lesions. Immuno-peroxidase staining 
can detect viral antigens in formalin-fixed or frozen tissues.  
Paired acute and convalescent serum samples should be 
collected to diagnose acute disease. Serology is also helpful 
in surveillance and to confirm the absence of infection 
before vaccination. 
Recommended actions if 
equine viral arteritis is suspected 
Notification of authorities 
Equine viral arteritis is a reportable disease in many 
states. Each state should be checked for specific 
regulations.  
Federal: Area Veterinarians in Charge (AVIC): 
http://www.aphis.usda.gov/animal_health/area_offices/ 
State Veterinarians:   
http://www.usaha.org/Portals/6/StateAnimalHealthOfficials
.pdf 
Control 
Acutely infected horses should be isolated to prevent 
transmission in secretions and excretions. Precautions 
should also be taken to avoid spreading the virus on 
fomites. EAV is readily inactivated by detergents, common 
disinfectants and lipid solvents. No specific treatment is 
available; however, most healthy horses other than young 
foals recover on their own. Good nursing and symptomatic 
treatment should be used in severe cases. Vaccination can 
also help contain outbreaks.  
Venereal transmission can be controlled by good 
management and vaccination. To protect pregnant mares 
from abortion, they should be separated from other horses 
and maintained in small groups according to their predicted 
foaling dates. Newly acquired horses should be isolated for 
3 to 4 weeks. Vaccination appears to prevent uninfected 
stallions from becoming long term carriers. Stallions that 
are not carriers should be vaccinated before the start of the 
breeding season. Prepubertal colts are given the vaccine 
when they are 6-12 months old. Carrier stallions are 
identified and bred only to well vaccinated or naturally 
seropositive mares. Similarly, semen that contains EAV 
should be used only in these mares. Because first-time 
vaccinates may shed field viruses for a short time after 
exposure, these mares should be isolated from seronegative 
horses, particularly pregnant mares, for three weeks after 
breeding. Naturally infected mares and those that are not 
first-time vaccinates are isolated for 24-48 hours, to protect 
other horses from the viruses present in semen.  
Carrier stallions should be housed where they can be 
physically separated from uninfected horses; in one case, 
stallions apparently became infected by indirect exposure to 
semen. However, this appears to be rare. EAV is sensitive 
to sunlight and low humidity, and uninfected stallions have 
been kept near carriers for years without infection. 
Excellent hygiene and decontamination of fomites should 
be practiced when breeding infected horses or collecting 
semen. Although some experimental methods may be 
promising, there is no proven method to eliminate carriage 
in stallions.  
Mandatory notification, annual testing, the 
identification of carrier stallions and control of transmission 
from these animals, and selective vaccination are being 
used in New Zealand to eradicate equine viral arteritis.  
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Public Health 
There is no indication that equine arteritis virus can 
infect humans. 
Internet Resources 
Food and Agriculture Organization of the United Nations 
(FAO). Manual for the Recognition of Exotic Diseases 
of Livestock  
http://www.spc.int/rahs/  
The Merck Veterinary Manual 
http://www.merckvetmanual.com/mvm/index.jsp  
USDA APHIS. Equine viral arteritis 
http://www.aphis.usda.gov/animal_health/animal_disea
ses/eva/  
World Organization for Animal Health (OIE) 
http://www.oie.int  
OIE Manual of Diagnostic Tests and Vaccines for  
Terrestrial Animals  
http://www.oie.int/international-standard-
setting/terrestrial-manual/access-online/ 
OIE Terrestrial Animal Health Code 
http://www.oie.int/international-standard-
setting/terrestrial-code/access-online/ 
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